Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 2/20 | 0.48 |
| ▸ | FNTB | P49356 | 2/20 | 0.48 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL581108 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA | |
| SCHEMBL3505617 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA | |
| SCHEMBL1054427 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA | |
| SCHEMBL4055143 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA | |
| SCHEMBL3503715 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA | |
| SCHEMBL3503710 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA | |
| SCHEMBL7707401 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA | |
| SCHEMBL581109 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA | |
| SCHEMBL756947 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA | |
| SCHEMBL4055149 | 1.00 | ALDH1A1 (0.61) | ALDH1A1ALOX15TRPV1TSHRDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-120161191-A | Marker composition for colorectal cancer detection and application thereof | 上海百趣生物医学科技有限公司 | 2025-06-17 | — | — | CN | disclosed |
| WO-2025096734-A1 | MICROCAPSULES | FMC CORPORATION (US) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | disclosed |
| EP-4440342-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2024-10-09 | — | — | EP | disclosed |
| CN-118714936-A | Methods and uses of microbial compositions, components or metabolites for the treatment of vagal nerve related diseases, disorders and conditions | 奇迹生物公司 | 2024-09-27 | — | — | CN | disclosed |
| EP-4401745-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING NEURODEGENERATIVE DISEASES | MarvelBiome, Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| CN-118265532-A | Methods and uses of microbiome compositions, components or metabolites for treating neurodegenerative diseases | 奇迹生物公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-116183889-A | Marker composition for colorectal cancer detection and application thereof | 上海百趣生物医学科技有限公司 | 2023-05-30 | — | — | CN | disclosed |
| WO-2023044076-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING NEURODEGENERATIVE DISEASES | MarvelBiome, Inc. (US) | 2023-03-23 | — | — | WO | disclosed |
| CN-113993378-B | Insect repellent composition | 环球生物生命有限公司 | 2022-06-28 | — | — | CN | disclosed |
| US-20220159950-A1 | INSECT REPELLING COMPOSITION | GLOBAL BIOLIFE INC. | 2022-05-26 | — | — | US | disclosed |
| US-11246310-B2 | Insect repelling composition | GLOBAL BIOLIFE INC. (US) | 2022-02-15 | — | — | US | disclosed |
| CN-113993378-A | Insect repellent composition | 环球生物生命有限公司 | 2022-01-28 | — | — | CN | disclosed |
| EP-3920698-A1 | INSECT REPELLING COMPOSITION | Global Biolife Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| US-20200253199-A1 | INSECT REPELLING COMPOSITION | GLOBAL BIOLIFE INC. | 2020-08-13 | — | — | US | disclosed |
| WO-2020163696-A1 | INSECT REPELLING COMPOSITION | GLOBAL BIOLIFE INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| US-PP12425-P2 | Pelargonium graveolens plant named ‘Narmada’ | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | IAPP, GPR119, FAHD1 | ALDH1A1 1370/4885ALOX15 2075/4885TRPV1 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.